Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFD | P00746 | 17/20 | 0.50 |
| ▸ | F11 | P03951 | 3/20 | 0.45 |
| ▸ | TPSB2 | P20231 | 3/20 | 0.45 |
| ▸ | PLG | P00747 | 1/20 | 0.45 |
| ▸ | PLAU | P00749 | 1/20 | 0.45 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.45 |
| ▸ | F7 | P08709 | 1/20 | 0.45 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.37 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.36 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.36 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.36 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23217521 | 1.00 | CFD (0.50) | CFDF11TPSB2PLGPLAU | |
| SCHEMBL30009841 | 0.90 | CFD (0.59) | CFDF11TPSB2PLGPLAU | |
| SCHEMBL23217761 | 0.90 | CFD (0.59) | CFDF11TPSB2PLGPLAU | |
| SCHEMBL30010309 | 0.89 | CFD (0.51) | CFDF11TPSB2PLGPLAU | |
| SCHEMBL23217268 | 0.89 | CFD (0.51) | CFDF11TPSB2PLGPLAU | |
| SCHEMBL23217592 | 0.89 | CFD (0.50) | CFDF11TPSB2PLGPLAU | |
| SCHEMBL30010535 | 0.89 | CFD (0.50) | CFDF11TPSB2PLGPLAU | |
| SCHEMBL23217860 | 0.89 | CFD (0.51) | CFDF11TPSB2PLGPLAU | |
| SCHEMBL23217477 | 0.87 | CFD (0.49) | CFDF11TPSB2PLGPLAU | |
| SCHEMBL30010482 | 0.87 | CFD (0.49) | CFDF11TPSB2PLGPLAU |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4041717-A1 | ORAL COMPLEMENT FACTOR D INHIBITORS | Biocryst Pharmaceuticals, Inc. (US) | 2022-08-17 | — | — | EP | disclosed |